G. Le Guenno

4.7k total citations
49 papers, 946 citations indexed

About

G. Le Guenno is a scholar working on Hematology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, G. Le Guenno has authored 49 papers receiving a total of 946 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 15 papers in Physiology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in G. Le Guenno's work include Vasculitis and related conditions (9 papers), Sarcoidosis and Beryllium Toxicity Research (8 papers) and Platelet Disorders and Treatments (8 papers). G. Le Guenno is often cited by papers focused on Vasculitis and related conditions (9 papers), Sarcoidosis and Beryllium Toxicity Research (8 papers) and Platelet Disorders and Treatments (8 papers). G. Le Guenno collaborates with scholars based in France, United States and United Kingdom. G. Le Guenno's co-authors include M. Ruivard, Alfred Mahr, V. Rieu, Loı̈c Guillevin, Vincent Grobost, Caroline Heijl, Mikkel Faurschou, Lionel Galicier, Louis Terriou and Béatrice Morio and has published in prestigious journals such as Blood, Neurology and Clinical Infectious Diseases.

In The Last Decade

G. Le Guenno

42 papers receiving 925 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Le Guenno France 16 322 321 286 240 219 49 946
Ann Knight Sweden 17 337 1.0× 418 1.3× 183 0.6× 154 0.6× 159 0.7× 30 937
Daiki Nakagomi Japan 16 470 1.5× 355 1.1× 160 0.6× 105 0.4× 104 0.5× 61 906
Mathilde de Menthon France 12 400 1.2× 381 1.2× 359 1.3× 81 0.3× 69 0.3× 26 1.1k
Kyriaki Boki Greece 21 761 2.4× 273 0.9× 204 0.7× 122 0.5× 97 0.4× 54 1.2k
H. Devilliers France 17 637 2.0× 405 1.3× 97 0.3× 115 0.5× 96 0.4× 69 990
G. Maigné France 15 362 1.1× 451 1.4× 92 0.3× 110 0.5× 230 1.1× 37 723
Carla Maldini France 13 525 1.6× 532 1.7× 151 0.5× 99 0.4× 53 0.2× 20 1.0k
Per Eriksson Sweden 23 551 1.7× 553 1.7× 364 1.3× 133 0.6× 180 0.8× 64 1.6k
Stéphan Pavy France 17 604 1.9× 139 0.4× 200 0.7× 187 0.8× 98 0.4× 32 1.0k
R. Pérez-Álvarez Spain 19 599 1.9× 488 1.5× 640 2.2× 122 0.5× 99 0.5× 25 1.6k

Countries citing papers authored by G. Le Guenno

Since Specialization
Citations

This map shows the geographic impact of G. Le Guenno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Le Guenno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Le Guenno more than expected).

Fields of papers citing papers by G. Le Guenno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Le Guenno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Le Guenno. The network helps show where G. Le Guenno may publish in the future.

Co-authorship network of co-authors of G. Le Guenno

This figure shows the co-authorship network connecting the top 25 collaborators of G. Le Guenno. A scholar is included among the top collaborators of G. Le Guenno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Le Guenno. G. Le Guenno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lambotte, O., Marion Malphettes, Louis Terriou, et al.. (2025). Pure Red Cell Aplasia Associated With Thymic Tumors, a Nationwide Retrospective Study. American Journal of Hematology. 100(12). 2230–2237.
2.
Guenno, G. Le, et al.. (2025). Entéropathies inflammatoires associées aux déficits immunitaires humoraux primitifs. La Revue de Médecine Interne. 46. A74–A74.
3.
Grobost, Vincent, et al.. (2024). Intravenous immunoglobulins for the treatment of prolonged COVID-19 in immunocompromised patients: a brief report. Frontiers in Immunology. 15. 1399180–1399180. 4 indexed citations
4.
Gangloff, Yann‐Gaël, Guilaine Boursier, C. Deligny, et al.. (2023). H syndrome mimicking Erdheim Chester disease: new entity and therapeutic perspectives. Haematologica. 108(8). 2255–2260. 3 indexed citations
5.
Lobbes, Hervé, Jean‐Christophe Lega, G. Le Guenno, M. Ruivard, & Sabine Mainbourg. (2023). Treatment strategy for acquired pure red cell aplasia: a systematic review and meta-analysis. Blood Advances. 7(21). 6451–6465. 9 indexed citations
6.
Desbois, A.C., Bastien Joubert, Cécile‐Audrey Durel, et al.. (2022). Prognostic Factors and Treatment Efficacy in Spinal Cord Sarcoidosis: An Observational Cohort With Long-term Follow-up.. SPIRE - Sciences Po Institutional REpository. 1 indexed citations
7.
Desbois, A.C., Bastien Joubert, Cécile‐Audrey Durel, et al.. (2022). Prognostic Factors and Treatment Efficacy in Spinal Cord Sarcoidosis. Neurology. 98(14). e1479–e1488. 9 indexed citations
8.
Guenno, G. Le, et al.. (2021). Cardiac sarcoidosis: systematic review of the literature on corticosteroid and immunosuppressive therapies. European Respiratory Journal. 59(5). 2100449–2100449. 19 indexed citations
9.
Guenno, G. Le, et al.. (2021). Case Report: TNFα Antagonists Are an Effective Therapy in Cardiac Sarcoidosis. Frontiers in Cardiovascular Medicine. 8. 676407–676407. 6 indexed citations
10.
Gerfaud‐Valentin, Mathieu, A. Hot, Sylvain Audia, et al.. (2021). Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patients. Lara D. Veeken. 61(9). 3627–3639. 20 indexed citations
11.
Prudent, Elsa, G. Le Guenno, Stijn Jonckheere, et al.. (2018). Fluorescent in situ hybridization can be used as a complementary assay for the diagnosis of Tropheryma whipplei infection. Infection. 47(2). 317–321. 6 indexed citations
12.
Lobbes, Hervé, Vincent Grobost, Richard Lemal, et al.. (2018). Efficacy of bortezomib in non‐IgM type I cryoglobulinaemic vasculitis: a single‐centre retrospective case series. European Journal Of Haematology. 101(5). 635–642. 4 indexed citations
13.
Jachiet, M., Maxime Samson, Vincent Cottin, et al.. (2016). 015 Anti-IgE monoclonal antibody (omalizumab) in refractory and relapsing eosinophilic granulomatosis with polyangiitis: data from 17 patients. Journal of Investigative Dermatology. 136(9). S163–S163. 1 indexed citations
14.
Puéchal, Xavier, Gérald Raverot, H. Gil, et al.. (2015). Pituitary Involvement in Granulomatosis With Polyangiitis. Medicine. 94(16). e748–e748. 47 indexed citations
15.
Michel, Marc, Louis Terriou, Françoise Roudot‐Thoraval, et al.. (2015). A Multi-Centre Randomized and Double-Blind Controlled Trial of Rituximab for Warm Autoimune Hemolytic Anemia in Adults. Blood. 126(23). 3338–3338. 2 indexed citations
16.
Terrier, Benjamin, Alexandre Karras, Jean‐Emmanuel Kahn, et al.. (2013). The Spectrum of Type I Cryoglobulinemia Vasculitis. Medicine. 92(2). 61–68. 125 indexed citations
17.
Mahr, Alfred, Caroline Heijl, G. Le Guenno, & Mikkel Faurschou. (2013). ANCA-associated vasculitis and malignancy: Current evidence for cause and consequence relationships. Best Practice & Research Clinical Rheumatology. 27(1). 45–56. 61 indexed citations
18.
Guenno, G. Le, et al.. (2012). L’hyperferritinémie en consultation de médecine interne. Étude rétrospective portant sur 523 patients. La Revue de Médecine Interne. 33. S44–S45.
19.
Mahévas, Matthieu, Laurent Chiche, Y. Uzunhan, et al.. (2011). Association of Sarcoidosis and Immune Thrombocytopenia. Medicine. 90(4). 269–278. 18 indexed citations
20.
Dhôte, R., G. Le Guenno, Christian Pagnoux, et al.. (2010). CO099Atteinte trachéale au cours de la maladie de Wegener. La Revue de Médecine Interne. 31. S389–S390.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ann Knight Breakdown of academic impact, for papers by Daiki Nakagomi Breakdown of academic impact, for papers by Mathilde de Menthon Breakdown of academic impact, for papers by Kyriaki Boki Breakdown of academic impact, for papers by H. Devilliers Breakdown of academic impact, for papers by G. Maigné Breakdown of academic impact, for papers by Carla Maldini Breakdown of academic impact, for papers by Per Eriksson Breakdown of academic impact, for papers by Stéphan Pavy Breakdown of academic impact, for papers by R. Pérez-Álvarez
Rankless by CCL
2026